Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma

British Journal of Ophthalmology

Volumn 83, Issue 4, 1999, Pages 448-451

  De Smet, Marc D ^a,d   Vancs, Virginia Stark ^b   Kohler, David ^c   Solomon, Diane ^b   Chan, Chi Chao ^a  

^a Laboratory of Immunology   (Netherlands)

^b Italian National Cancer Institute   (Netherlands)

^c Warren G Magnuson Clinical Center   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; INTERLEUKIN 10; INTERLEUKIN 6; METHOTREXATE; THIOTEPA;

ADULT; ANTERIOR EYE CHAMBER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CYTOLOGY; DRUG CLEARANCE; EYE CANCER; FEMALE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PRIORITY JOURNAL; TUMOR GROWTH; VITREOUS BODY;

EID: 0032936572     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.4.448     Document Type: Article

References (32)

1. DeAngelis LM, Yahalom JY, Heinemann M-H, et al. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 1990;40:80-6.
2. DeAngelis LM, Yahalom J, Thaler HT, et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992;10:635-13.
3. Char DH, Ljung BM, Miller T, et al. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 1988;95:625-30.
4. Boiardi A, Silvani A, Valentini S, et al. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data. J Neurol 1993;241:96-100.
5. Chamberlain MC, Levin VA. Adjuvant chemotherapy for primary lymphoma of the central nervous system. Arch Neurol 1990;47:1113-16.
6. Pollack IF, Lunsford LD, Flickinger JC, et al. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989;63:939-47.
7. Rouwen AJP, Wijermans PW, Boen-Tan TN, et al. Intraocular non-Hodgkin's lymphoma treated with systemic and intrathecal chemotherapy and radiotherapy. A case report and review of the literature. Graefes Arch Clin Exp Ophthalmol 1989;227:355-9.
8. Peterson K, Gordon KB, Heinemann MH, et al. The clinical spectrum of ocular lymphoma. Cancer 1993;72:843-9.
9. Brown GC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology 1982;89:1494-501.
10. Archer DB, Amoaku WMK, Gardiner TA. Radiation retinopathy - clinical, histopathological, ultrastructural and experimental correlations. Eye 1991;5:239-51.
11. Chee PHY Radiation retinopathy. Am J Ophthalmol 1968;66:860-5.
12. De la Paz MA, Boniuk M. Fundus manifestations of orbital disease and treatment of orbital disease. Surv Ophthalmol 1995;40:3-21.
13. Brown GC, Shields JA, Sanborn G, et al. Radiation optic neuropathy. Ophthalmology 1982;89:1489-93.
14. Chan RC, Shukovsky LJ. Effects of irradiation on the eye. Ther Radial 1976;120:673-5.
15. Merriam GR, Jr, Szechter A, Focht EF. The effects of ionizing radiations on the eye. Front Radiation Ther Onc 1972;6: 346-85.
16. Viebahn M, Barricks ME, Osterloh MD. Synergism between diabetic and radiation retinopathy: case report and review. Br J Ophthalmol 1991;75:629-62.
17. Plowman PN, Montefiore DS, Lightman S. Multiagent chemotherapy in the salvage cure of ocular lymphoma relapsing after radiotherapy, Clin Oncol 1993;5:315-16.
18. de Smet MD, Stark-Vancs V, Kohler DR, et al. Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol 1996;121:442-4.
19. Seregard S, Kock E, af Trampe E. Intravitreal chemotherapy for recurrent retinoblastoma in an only eye. Br J Ophthalmol 1995;79:194-5.
20. Fisbburne BC, Wilson DJ, Rosenbaum JT, et al. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997;115:1152-6.
21. Nussenblatt RB, de Smet M, Podgor M, et al. The use of the flare photometry in the detection of cytomegalic virus retinitis in AIDS patients. AIDS 1994,8:135-6.
22. Guex-Crosier Y, Pittet N, Herbort CP. Evaluation of laser flare-cell photometry in the appraisal and management of intraocular inflammation in uveitis. Ophthalmology 1994; 101:728-35.
23. Davis JL, Solomon D, Nussenblatt RB, et al. Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology 1992;99:250-6.
24. Chan CC, Whitcup SM, Solomon D, et al. Interieukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 1995;120:671-3.
25. 2 in children with acute lymphoblastic leukemia. Cancer 1987;60:5-13.
26. Ettinger LJ, Chervinsky DS, Freeman AI, et al. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non Hodgkin's lymphoma. Cancer 1982;50:1676-82.
27. Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous ventricular and lumbar injections. N Engl J Med 1975;293: 161-6.
28. Baumann MA, Ritch PS, Hande KR, et al. Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 1986; 57:1273-5.
29. Liang B, Grant R, Junck L, et al. Primary central nervous system lymphoma: treatment with multiagent systemic and intrathecal chemotherapy with radiation therapy. Int J Oncol 1993;3:1001-1.
30. Rousset F, Garcia E, Defrance T, et al. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Nat Acad Sci USA 1992;89: 1890-3.
31. Blay JY, Burdin N, Rousset F, et al. Serum interleukin-10 in non-Hodgkin's lymphoma; a prognostic factor. Blood 1993;82:2169-74.
32. Ford RJ, Tamayo A, Ambrus JL. The role of growth factors in human lymphomas. Curr Top Microbiol Immunol 1992;182:341-7.